Fig. 7: Pattern of USP35 negatively regulates the MAVS signaling pathway to attenuate type I interferon production.
From: Deubiquitination enzyme USP35 negatively regulates MAVS signaling to inhibit anti-tumor immunity

RNA virus is induced by exogenous RNA and cytoplasmic dsRNA, which activates the MAVS signaling pathway. However, USP35 inhibits the MAVS-TBK1-IRF3 signaling pathway through its deubiquitinating activity, thereby attenuating the production of type I interferons. The schematic was created using the Figdraw website.